University of Dundee;GlaxoSmithKline Intellectual Property Development Limited
发明人:
Stephen BRAND,Peter George DODD,Eun Jung KO,Maria MARCO MARTIN,Timothy James MILES,Lars Henrik SANDBERG,Michael George THOMAS,Stephen THOMPSON
申请号：
US15750896
公开号：
US20180222911A1
申请日:
2016.08.03
申请国别(地区):
US
年份:
2018
代理人:
摘要：
A compound of Formula (I), or a salt thereof,compositions comprising the compound, processes for its preparation and its use in therapy, for example in the treatment of parasitic diseases such as Chagas disease, Human African Trypanosomiasis (HAT), Animal African trypanosomiasis (AAT) and leishmaniasis, particularly visceral leishmaniasis (VL).
